CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) FOR ADVANCED GASTRIC CANCER

被引：0
|
作者：
Maeda, O. [1 ]
Ando, T. [2 ]
Ishiguro, K. [1 ]
Watanabe, O. [2 ]
Miyahara, R. [2 ]
Funasaka, K. [3 ]
Ando, Y. [4 ]
Goto, H. [2 ,3 ]
机构：
[1] Nagoya Univ, Dept Adv Res Gastroenterol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[2] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[3] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan
[4] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [41] A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer
    Cho, EK
    Lee, WK
    Im, SA
    Lee, SN
    Park, SH
    Bang, SM
    Park, DK
    Park, YH
    Shin, DB
    Lee, JH
    ONCOLOGY, 2005, 68 (4-6) : 333 - 340
  • [42] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    Kim, TW
    Kang, YK
    Ahn, JH
    Chang, HM
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1893 - 1898
  • [43] Preliminary data on perioperative chemotherapy with docetaxel, oxaliplatin and capecitabine (DOC) in patients with locally advanced unresectable gastric cancer
    Viudez, A.
    Rodriguez, J.
    Chopitea, A.
    De la Camara, J.
    Viteri, S.
    Olier, C.
    Reyna, C.
    Garcia-Foncillas, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 99 - 99
  • [44] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Sasaki, Kinro
    Onodera, Shinichi
    Otsuka, Kichiro
    Satomura, Hitoshi
    Kurayama, Eigo
    Kubo, Tsukasa
    Takahashi, Masakazu
    Ito, Jun
    Nakajima, Masanobu
    Yamaguchi, Satoru
    Miyachi, Kazuhito
    Kato, Hiroyuki
    MEDICAL ONCOLOGY, 2017, 34 (08)
  • [45] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Kinro Sasaki
    Shinichi Onodera
    Kichiro Otsuka
    Hitoshi Satomura
    Eigo Kurayama
    Tsukasa Kubo
    Masakazu Takahashi
    Jun Ito
    Masanobu Nakajima
    Satoru Yamaguchi
    Kazuhito Miyachi
    Hiroyuki Kato
    Medical Oncology, 2017, 34
  • [46] Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer
    Kazuhiro Migita
    Atsushi Nashimoto
    Hiroshi Yabusaki
    Atsushi Matsuki
    Masaki Aizawa
    International Journal of Clinical Oncology, 2016, 21 : 102 - 109
  • [47] PALLIATIVE CHEMOTHERAPY WITH DOCETAXEL-CISPLATIN FOR ADVANCED GASTRIC CANCER IN A NON SELECTED PATIENT POPULATION IN CHILE
    Mueller, B.
    Matamala, L.
    Carcamo, M.
    Luis, V
    Roberto, T.
    ANNALS OF ONCOLOGY, 2009, 20 : 84 - 84
  • [48] Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication
    Ma, Yanlei
    Qin, Huanlong
    Zheng, Qi
    Wang, Yu
    Wang, Zhiguo
    Yang, Zhe
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1089 - 1095
  • [49] Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication
    Yanlei Ma
    Huanlong Qin
    Qi Zheng
    Yu Wang
    Zhiguo Wang
    Zhe Yang
    Medical Oncology, 2010, 27 : 1089 - 1095
  • [50] BIWEEKLY COMBINATION CHEMOTHERAPY OF DOCETAXEL, IRINOTECAN AND CISPLATIN AS SECOND-LINE TREATMENT FOR ADVANCED GASTRIC CANCER
    Denda, T.
    Sudo, K.
    Nakamura, K.
    Hara, T.
    Yamaguchi, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
12345